BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 21108954)

  • 1. The role of fragile X mental retardation protein in major mental disorders.
    Fatemi SH; Folsom TD
    Neuropharmacology; 2011 Jun; 60(7-8):1221-6. PubMed ID: 21108954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory.
    Sawicka K; Hale CR; Park CY; Fak JJ; Gresack JE; Van Driesche SJ; Kang JJ; Darnell JC; Darnell RB
    Elife; 2019 Dec; 8():. PubMed ID: 31860442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The state of synapses in fragile X syndrome.
    Pfeiffer BE; Huber KM
    Neuroscientist; 2009 Oct; 15(5):549-67. PubMed ID: 19325170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragile X syndrome: From protein function to therapy.
    Bagni C; Oostra BA
    Am J Med Genet A; 2013 Nov; 161A(11):2809-21. PubMed ID: 24115651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of reduced expression of fragile X mental retardation protein in neurons and increased expression in astrocytes in idiopathic and syndromic autism (duplications 15q11.2-q13).
    Wegiel J; Brown WT; La Fauci G; Adayev T; Kascsak R; Kascsak R; Flory M; Kaczmarski W; Kuchna I; Nowicki K; Martinez-Cerdeno V; Wisniewski T; Wegiel J
    Autism Res; 2018 Oct; 11(10):1316-1331. PubMed ID: 30107092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features.
    Baker EK; Arpone M; Aliaga SM; Bretherton L; Kraan CM; Bui M; Slater HR; Ling L; Francis D; Hunter MF; Elliott J; Rogers C; Field M; Cohen J; Cornish K; Santa Maria L; Faundes V; Curotto B; Morales P; Trigo C; Salas I; Alliende AM; Amor DJ; Godler DE
    Mol Autism; 2019; 10():21. PubMed ID: 31073396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
    De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
    Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome profiling of the prefrontal cortex of Fmr1 knockout mouse reveals enhancement of complement and coagulation cascades.
    Gao MM; Shi H; Yan HJ; Long YS
    J Proteomics; 2023 Mar; 274():104822. PubMed ID: 36646274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
    Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
    Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic vesicle dynamic changes in a model of fragile X.
    Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
    Mol Autism; 2016; 7():17. PubMed ID: 26933487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysine acetylome profiling in mouse hippocampus and its alterations upon FMRP deficiency linked to abnormal energy metabolism.
    Wu YY; Yang C; Yan HJ; Lu P; Zhang L; Feng WC; Long YS
    J Proteomics; 2022 Oct; 269():104720. PubMed ID: 36089189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-Specific FMRP Roles in Experience-Dependent Remodeling of Olfactory Brain Innervation during an Early-Life Critical Period.
    Golovin RM; Vest J; Broadie K
    J Neurosci; 2021 Feb; 41(6):1218-1241. PubMed ID: 33402421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular biology of FMRP: new insights into fragile X syndrome.
    Richter JD; Zhao X
    Nat Rev Neurosci; 2021 Apr; 22(4):209-222. PubMed ID: 33608673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNAs and Fragile X Syndrome.
    Lin SL
    Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures.
    Myrick LK; Deng PY; Hashimoto H; Oh YM; Cho Y; Poidevin MJ; Suhl JA; Visootsak J; Cavalli V; Jin P; Cheng X; Warren ST; Klyachko VA
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):949-56. PubMed ID: 25561520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF in fragile X syndrome.
    Castrén ML; Castrén E
    Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics.
    Bagni C; Tassone F; Neri G; Hagerman R
    J Clin Invest; 2012 Dec; 122(12):4314-22. PubMed ID: 23202739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction.
    Prieto M; Folci A; Martin S
    Mol Psychiatry; 2020 Aug; 25(8):1688-1703. PubMed ID: 31822816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FMRP ribonucleoprotein complexes and RNA homeostasis.
    Suardi GAM; Haddad LA
    Adv Genet; 2020; 105():95-136. PubMed ID: 32560791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.